ARCHIVES

Two Court Rulings Conflict In Paclitaxel Patent Battle.

This article is from The Cancer Letter archive.

Vol. 28 No. 03 | January 18, 2002

Download PDF Visit The Full Archive

Related Articles

Freestanding Cancer Centers May Be The “Missing Ingredient In Cancer Treatment,” DeVita Believes

January 11, 1985

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014

DCT Board Approves More Than $25 Million In Contract Recompetitions, Two New Contracts

February 23, 1990

Cancer Researchers Ask Congress for Full Bypass Budge Funding

April 27, 1990

Interferon Interest Zooms; NCI Awarding Production Contracts, Proceeds With Plans For Clinical Trials

March 14, 1980